LOGIN  |  REGISTER
C4 Therapeutics

Phreesia Announces Chief Financial Officer Transition

March 22, 2023 | Last Trade: US$23.93 0.46 -1.89

WILMINGTON, Del. / Mar 22, 2023 / Business Wire / Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia’s Chief Financial Officer. Gandhi will succeed Randy Rasmussen, effective March 24, 2023. Rasmussen will serve as a Strategic Advisor to the Company for a period of time, to facilitate a smooth transition of his responsibilities.

Gandhi has over 25 years of experience as an operating executive with healthcare services and technology companies and as an investment research analyst following the space. He joined Phreesia in 2019 in preparation for its initial public offering and most recently served as Senior Vice President, Investor Relations, and a member of the executive leadership team.

“Balaji’s extensive knowledge of Phreesia and experience successfully partnering with our leadership team uniquely qualify him to transition to the CFO role. Additionally, Balaji is an experienced public company executive with a proven track record of communicating effectively with the investment community,” said Chaim Indig, Chief Executive Officer and Co-Founder of Phreesia. “I look forward to continuing to work closely with Balaji as we execute on our near-term plan and drive long-term value for all of our stakeholders.”

“On behalf of Phreesia, I want to thank Randy for his leadership in establishing strong controls, systems and processes across our finance organization which has enabled us to scale as a public company over the past three years,” added Indig. “We wish him all the best in his future endeavors.”

ABOUT PHREESIA

Phreesia provides healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, convenient experience, while enabling our clients to enhance clinical care and drive efficiency.

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB